Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.79 USD | +12.69% | -30.07% | +483.67% |
Evolution of the average Target Price on Candel Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Candel Therapeutics, Inc.
Credit Suisse | |
UBS | |
HC Wainwright | |
BMO Capital | |
Jefferies & Co. |
EPS Revisions
- Stock Market
- Equities
- CADL Stock
- Consensus Candel Therapeutics, Inc.